Pictor develops a targeted proteomic platform comprising PictArray, PictImager and Pictorial software to enable multi-analyte proteomic assays for human and animal health, pharma and reference laboratory markets. The system is designed to deliver up to 20 protein targets from a single sample in under two hours and to reduce per-sample costs and workflow complexity. In its first year at its U.S. headquarters the company launched seven commercial products, secured four strategic partnerships, and expanded its leadership team. Pictor has laboratory and commercial operations in New Zealand, Australia and India and holds an IP portfolio of 16 issued patents, five pending and seven registered trademarks. The company has raised approximately $30 million to date and is pursuing licensing discussions and a potential U.S. Series A to further expand commercial operations, platform development and manufacturing.

Total raised

$19M

Funding rounds

4

Latest round

Equity

Latest activity

Jun 2026